Emerging multidrug-resistant hybrid pathotype shiga toxin-producing escherichia coil O80 and related strains of clonal complex 165, Europe

Loading...
Thumbnail Image
Identifiers
ISSN: 1080-6040
E-ISSN: 1080-6059

Publication date

Advisors

Tutors

Editors

Journal Title

Journal ISSN

Volume Title

Publisher

Centers for Disease Control and Prevention
Metrics
Google Scholar
lacobus
Export

Research Projects

Organizational Units

Journal Issue

Abstract

Enterohemorrhagic Escherichia coli serogroup O80, involved in hemolytic uremic syndrome associated with extraintestinal infections, has emerged in France. We obtained circularized sequences of the O80 strain RDEx444, responsible for hemolytic uremic syndrome with bacteremia, and noncircularized sequences of 35 O80 E. coli isolated from humans and animals in Europe with or without Shiga toxin genes. RDEx444 harbored a mosaic plasmid, pR444_A, combining extraintestinal virulence determinants and a multidrug resistance– encoding island. All strains belonged to clonal complex 165, which is distantly related to other major enterohemorrhagic E. coli lineages. All stx-positive strains contained eae-ξ, ehxA, and genes characteristic of pR444_A. Among stx-negative strains, 1 produced extended-spectrum β-lactamase, 1 harbored the colistin-resistance gene mcr1, and 2 possessed genes characteristic of enteropathogenic and pyelonephritis E. coli. Because O80–clonal complex 165 strains can integrate intestinal and extraintestinal virulence factors in combination with diverse drug-resistance genes, they constitute dangerous and versatile multidrug-resistant pathogens

Description

Bibliographic citation

Cointe, A., Birgy, A., Mariani Kurkdjian, P., Logouri, S., Courroux, C., Blanco, J. et al. (2018). Emerging multidrug-resistant hybrid pathotype shiga toxin–producing escherichia coli O80 and related strains of clonal complex 165, Europe. Emerg. Infect. Dis., vol. 24,12, 2062-2069

Relation

Has part

Has version

Is based on

Is part of

Is referenced by

Is version of

Requires

Sponsors

We thank Roger Stephan and Lothar Beutin for providing the strains from Switzerland and Germany, respectively. This work was financed by Fonds d’Etudes et de Recherche du Corps Médical, AP-HP. Work in the Laboratorio de Referencia de Escherichia coli was financed by grant no. ED431C-2017-57 from Consellería de Cultura, Educación e Ordenación Universitaria (Xunta de Galicia) and the European Regional Development Fund

Rights

© 2018 by the authors. Licensee Centers for Disease Control and Prevention. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/)